Strategies to improve the immunogenicity of prM+E dengue virus type-2 DNA vaccine
© 2017, Allergy and Immunology Society of Thailand. All rights reserved. Background: An important goal for dengue vaccines is to induce a high and durable level of neutralizing antibody. Objective: Three strategies were investigated for improving the immunogenicity of a prM+E dengue serotype 2 (DENV...
Saved in:
Main Authors: | Ketloy C., Keelapang P., Prompetchara E., Suphatrakul A., Puttikhunt C., Kasinrerk W., Konishi E., Sittisombut N., Ruxrungtham K. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85018718658&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41153 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Strategies to improve the immunogenicity of prM+E dengue virus type-2 DNA vaccine
by: Chutitorn Ketloy, et al.
Published: (2018) -
Strategies to improve the immunogenicity of prM+E dengue virus type-2 DNA vaccine
by: Chutitorn Ketloy, et al.
Published: (2018) -
Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage
by: Keelapang P., et al.
Published: (2014) -
Novel anti-dengue monoclonal antibody recognizing conformational structure of the prM-E heterodimeric complex of dengue virus
by: Puttikhunt C., et al.
Published: (2014) -
Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage
by: Poonsook Keelapang, et al.
Published: (2018)